BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36967443)

  • 1. PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer.
    Gao S; Zhang W; Ma J; Ni X
    J Transl Med; 2023 Mar; 21(1):220. PubMed ID: 36967443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway.
    Lin Q; Chen Z; Shi W; Lv Z; Wan X; Gao K
    Cell Commun Signal; 2022 Nov; 20(1):177. PubMed ID: 36376931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway.
    Sun S; Ma J; Xie P; Wu Z; Tian X
    J Gene Med; 2020 Oct; 22(10):e3230. PubMed ID: 32436353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α.
    Lu M; Ge Q; Wang G; Luo Y; Wang X; Jiang W; Liu X; Wu CL; Xiao Y; Wang X
    Cell Death Dis; 2018 Oct; 9(10):1046. PubMed ID: 30315244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
    Wang Y; Chen Y; Bao L; Zhang B; Wang JE; Kumar A; Xing C; Wang Y; Luo W
    Cancer Res; 2020 Sep; 80(18):3880-3891. PubMed ID: 32699137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
    Cho KH; Yu SL; Cho DY; Park CG; Lee HY
    BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.
    Wang X; Peng J; Yang Z; Zhou PJ; An N; Wei L; Zhu HH; Lu J; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2019 Jan; 38(1):27. PubMed ID: 30665442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
    Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
    Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
    [No Abstract]   [Full Text] [Related]  

  • 15. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.
    Niu Y; Jin Y; Deng SC; Deng SJ; Zhu S; Liu Y; Li X; He C; Liu ML; Zeng Z; Chen HY; Zhong JX; Ye Z; Wang CY; Zhao G
    Oncogene; 2018 Mar; 37(13):1743-1758. PubMed ID: 29343850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DUSP28 promotes cell proliferation, migration, and invasion by Akt/β-catenin/Slug axis in breast cancer.
    Zhang J; Guo Y
    Acta Biochim Pol; 2022 Dec; 69(4):711-717. PubMed ID: 36520087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX2 promotes hypoxia-induced breast cancer cell migration by inducing NEDD9 expression and subsequent activation of Rac1/HIF-1α signaling.
    Wang Y; Bibi M; Min P; Deng W; Zhang Y; Du J
    Cell Mol Biol Lett; 2019; 24():55. PubMed ID: 31462898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA1 promotes the invasion and migration of pancreatic cancer cells potentially through the HIF-α/VEGF pathway.
    Sun X; Zhang Y; Li B; Yang H
    J Recept Signal Transduct Res; 2018 Aug; 38(4):352-358. PubMed ID: 30396299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular ATP promotes breast cancer invasion and epithelial-mesenchymal transition via hypoxia-inducible factor 2α signaling.
    Yang H; Geng YH; Wang P; Zhou YT; Yang H; Huo YF; Zhang HQ; Li Y; He HY; Tian XX; Fang WG
    Cancer Sci; 2019 Aug; 110(8):2456-2470. PubMed ID: 31148343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.